Pressure Biosciences Inc (OTCMKTS:PBIO) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $2.54 and traded as low as $2.80. Pressure Biosciences shares last traded at $2.80, with a volume of 655 shares changing hands.
Separately, ValuEngine upgraded shares of Pressure Biosciences from a “hold” rating to a “buy” rating in a research report on Tuesday, July 2nd.
The stock’s 50-day moving average price is $2.53 and its 200 day moving average price is $3.05. The firm has a market capitalization of $6.21 million, a price-to-earnings ratio of -0.18 and a beta of 1.26.
Pressure Biosciences Company Profile (OTCMKTS:PBIO)
Pressure BioSciences, Inc develops pressure cycling technology (PCT) solutions. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources.
Further Reading: What is dividend yield?
Receive News & Ratings for Pressure Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.